Wilson Martin
Reporting owner on Forms 3, 4 and 5, CIK 1704342.
Wilson Martin reported on 1 issuer in 3 filings, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RCKT · ROCKET PHARMACEUTICALS, INC.CIK 1281895 | officer (General Counsel) | 3 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RCKT · ROCKET PHARMACEUTICALS, INC.Common Stock | 2026-11-18 | S sold | -677 | $2.178 | 540,336 | Form 4 |
| RCKT · ROCKET PHARMACEUTICALS, INC.Common Stock | 2026-11-13 | S sold | -4,087 | $2.25 | 541,013 | Form 4 |
| RCKT · ROCKET PHARMACEUTICALS, INC.Common Stock | 2026-11-05 | S sold | -53,389 | $2.394 | 545,100 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001140361-26-045108 | ROCKET PHARMACEUTICALS, INC. | 2026-11-20 | ||
| Form 4 0001140361-26-044544 | ROCKET PHARMACEUTICALS, INC. | 2026-11-17 | ||
| Form 4 0001140361-26-042784 | ROCKET PHARMACEUTICALS, INC. | 2026-11-09 |